These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28465589)

  • 61. Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.
    Alfano D; Franco P; Stoppelli MP
    Front Cell Dev Biol; 2022; 10():818616. PubMed ID: 35493073
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer.
    Masucci MT; Minopoli M; Di Carluccio G; Motti ML; Carriero MV
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158766
    [TBL] [Abstract][Full Text] [Related]  

  • 63. uPAR: An Essential Factor for Tumor Development.
    Lv T; Zhao Y; Jiang X; Yuan H; Wang H; Cui X; Xu J; Zhao J; Wang J
    J Cancer; 2021; 12(23):7026-7040. PubMed ID: 34729105
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recent Applications of Retro-Inverso Peptides.
    Doti N; Mardirossian M; Sandomenico A; Ruvo M; Caporale A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445382
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells.
    Minopoli M; Sarno S; Cannella L; Tafuto S; Scognamiglio G; Gallo M; Fazioli F; Azzaro R; Apice G; De Angelis B; Tamborini E; Garofalo C; Pignochino Y; Mercatali L; Ibrahim T; Falcioni R; Valenti B; Maestro R; Scotlandi K; De Chiara A; Carriero MV
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34209309
    [TBL] [Abstract][Full Text] [Related]  

  • 66. COVID-19 and pneumonia: a role for the uPA/uPAR system.
    D'Alonzo D; De Fenza M; Pavone V
    Drug Discov Today; 2020 Aug; 25(8):1528-1534. PubMed ID: 32562843
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma.
    Minopoli M; Sarno S; Di Carluccio G; Azzaro R; Costantini S; Fazioli F; Gallo M; Apice G; Cannella L; Rea D; Stoppelli MP; Boraschi D; Budillon A; Scotlandi K; De Chiara A; Carriero MV
    Cells; 2020 Apr; 9(4):. PubMed ID: 32344648
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.
    Minopoli M; Botti G; Gigantino V; Ragone C; Sarno S; Motti ML; Scognamiglio G; Greggi S; Scaffa C; Roca MS; Stoppelli MP; Ciliberto G; Losito NS; Carriero MV
    J Exp Clin Cancer Res; 2019 Nov; 38(1):459. PubMed ID: 31703596
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells.
    Fratangelo F; Camerlingo R; Carriero MV; Pirozzi G; Palmieri G; Gentilcore G; Ragone C; Minopoli M; Ascierto PA; Motti ML
    Int J Oncol; 2018 Sep; 53(3):1149-1159. PubMed ID: 29956724
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications.
    Mahmood N; Mihalcioiu C; Rabbani SA
    Front Oncol; 2018; 8():24. PubMed ID: 29484286
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells.
    Ingangi V; Bifulco K; Yousif AM; Ragone C; Motti ML; Rea D; Minopoli M; Botti G; Scognamiglio G; Fazioli F; Gallo M; De Chiara A; Arra C; Grieco P; Carriero MV
    Oncotarget; 2016 Aug; 7(34):54474-54487. PubMed ID: 27323409
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.
    Minopoli M; Polo A; Ragone C; Ingangi V; Ciliberto G; Pessi A; Sarno S; Budillon A; Costantini S; Carriero MV
    Sci Rep; 2019 Aug; 9(1):12169. PubMed ID: 31434916
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs.
    Nakayama J; Makinoshima H
    Molecules; 2020 May; 25(10):. PubMed ID: 32455810
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.
    Carriero MV; Bifulco K; Ingangi V; Costantini S; Botti G; Ragone C; Minopoli M; Motti ML; Rea D; Scognamiglio G; Botti G; Arra C; Ciliberto G; Pessi A
    Sci Rep; 2017 May; 7(1):1312. PubMed ID: 28465589
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.
    Ragone C; Minopoli M; Ingangi V; Botti G; Fratangelo F; Pessi A; Stoppelli MP; Ascierto PA; Ciliberto G; Motti ML; Carriero MV
    J Exp Clin Cancer Res; 2017 Dec; 36(1):180. PubMed ID: 29216889
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.